Bensbaa Salma, Agerd Loubna, Boujraf Saïd, Araab Chadya, Aalouane Rachid, Rammouz Ismail, Ajdi Farida
Departments of Endocrinology, Diabetology and Nutrition, Fez, Morocco.
Clinical Neuroscience Laboratory, University of Fez, Fez, Morocco ; Department of Biophysics and Clinical MRI Methods, University of Fez, Fez, Morocco.
J Neurosci Rural Pract. 2014 Jul;5(3):250-3. doi: 10.4103/0976-3147.133576.
The global prevalence of diabetes is increasing worldwide. In Morocco, diabetes and depression are major public health problems, requiring improvement in their care. Diabetes and depression are associated with morbidity and early mortality. This association contributes to raising the risk of the complications that occur, while causing higher suffering to patients, as also an increased cost toward healthcare.
This study aims to assess the prevalence of depression in patients with type 2 diabetes (T2D), and identify the main risk factors for depression in this category of diabetic patients.
Type 2 diabetic patients and older than 18 years of age were recruited. The exclusion criteria included being type 1 diabetic, pregnant woman, hospitalized patients, a history of neurological disorders, such as, stroke, infectious episidodes, and history of psychiatric disorders. The individual patient data was collected through individual and confidential interviews lasting 30 minutes, at the end of the diabetology consultation, by the same diabetologist, trained to use the psychometric scales that were needed. The Moroccan-Arabic version of the Beck diagnostic scale of depression was used. Patients assessed with depressive disorders were reviewed in a specialized psychiatric consultation. The statistical analysis was achieved by using SPSS package (version 17). We retained a threshold P value of 0.05.
A cross-sectional study was conducted that included adults with type 2 diabetes. The depression diagnosis was performed using the Arabic version of the Beck Depression scale.
We included 142 patients with type 2 diabetes, with an average age of 56.26 years. The prevalence of depression was 33.1%. The risk factors recognized for depression were, lack of social security, hypertension, and a history of type 2 diabetes of more than five years.
In this study, we have focused on the frequent association of 'Type 2 diabetes and depression' and the risk of mutual aggravation of both pathologies that might require multidisciplinary healthcare, as well as, improvement in the risk factors of depression through improved access to healthcare, with the extension of social security. The stability of the healthcare personnel involved in the treatment of both chronic diseases, including diabetes and hypertension screening, should also be considered for better management of psychiatric complications.
全球糖尿病患病率在世界范围内呈上升趋势。在摩洛哥,糖尿病和抑郁症是主要的公共卫生问题,需要改善其治疗情况。糖尿病和抑郁症与发病率及早期死亡率相关。这种关联导致所发生并发症的风险增加,同时给患者带来更大痛苦,也增加了医疗保健成本。
本研究旨在评估2型糖尿病(T2D)患者中抑郁症的患病率,并确定这类糖尿病患者抑郁症的主要危险因素。
招募年龄在18岁以上的2型糖尿病患者。排除标准包括1型糖尿病患者、孕妇、住院患者、有神经系统疾病史(如中风、感染性发作)以及精神疾病史者。个体患者数据通过在糖尿病咨询结束时由同一位经过培训能使用所需心理测量量表的糖尿病专家进行的为期30分钟的单独保密访谈收集。使用了贝克抑郁诊断量表的摩洛哥阿拉伯语版本。被评估为患有抑郁症的患者在专门的精神科咨询中接受复查。使用SPSS软件包(版本17)进行统计分析。我们采用的P值阈值为0.05。
进行了一项横断面研究,纳入2型糖尿病成人患者。使用贝克抑郁量表阿拉伯语版本进行抑郁症诊断。
我们纳入了142例2型糖尿病患者,平均年龄为56.26岁。抑郁症患病率为33.1%。被确认的抑郁症危险因素为缺乏社会保障、高血压以及2型糖尿病病史超过五年。
在本研究中,我们关注了“2型糖尿病与抑郁症”的频繁关联以及两种病症相互加重的风险,这可能需要多学科医疗保健,并且通过改善医疗保健服务可及性以及扩大社会保障来改善抑郁症的危险因素。为了更好地管理精神科并发症,还应考虑参与治疗包括糖尿病和高血压筛查在内的两种慢性病的医护人员的稳定性。